Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04102709 · ClinicalTrials.gov registry record
Spire Medical Health Tag Actigraphy and Sleep Validation in Adults
A clinical trial, sponsored by Spire.
- Completed
- Registry status
- 45
- Enrollment target
NCT04102709: Completed study, sponsored by Spire.
NCT04102709 is a clinical trial that has completed, run by Spire. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04102709 has completed, sponsored by Spire.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data to validate the step- (actigraphy) and sleep-tracking performance of the Medical Health Tag device developed by Spire Health.
Primary Outcome
Accuracy of the Medical Health Tag for the measurement of steps to the Reference
Interventions
- DEVICE Health Tag
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-08-19 |
| Est. Completion | 2019-09-18 |
What the finished NCT04102709 record still lists
NCT04102709 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Health Tag is the first listed.
NCT04102709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04102709 about?
NCT04102709 is a clinical study titled "Spire Medical Health Tag Actigraphy and Sleep Validation in Adults". The purpose of this study is to collect data to validate the step- (actigraphy) and sleep-tracking performance of the Medical Health Tag device developed by Spire Health.
What is the current status of trial NCT04102709?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2019-08-19. Estimated completion is 2019-09-18.
What interventions are being tested in trial NCT04102709?
The interventions under investigation include: Health Tag (DEVICE).
Who is sponsoring clinical trial NCT04102709?
This trial is sponsored by Spire, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI